Zhang W, Wu X, Sun X, Wen J, et al. Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver metastases treated with EGFR tyrosine kinase inhibitors. BMC Cancer 2026 Jan 23. doi: 10.1186/s12885-026-15616.
PMID: 41578210